Visceral and subcutaneous fat in patients treated with olanzapine: a case series
Objectives: - We hypothesized that olanzapine may contribute to visceral adiposity, a core symptom of metabolic syndrome. - Methods: - Using computed tomography, we examined the effect of olanzapine on visceral and subcutaneous fat distribution, body mass index, fasting glu...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2010
|
| In: |
Clinical neuropharmacology
Year: 2010, Jahrgang: 33, Heft: 5, Pages: 248-249 |
| ISSN: | 1537-162X |
| DOI: | 10.1097/WNF.0b013e3181f0ec33 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1097/WNF.0b013e3181f0ec33 Verlag: https://journals.lww.com/clinicalneuropharm/Abstract/2010/09000/Visceral_and_Subcutaneous_Fat_in_Patients_Treated.7.aspx |
| Verfasserangaben: | Maria Gilles, Frank Hentschel, Georgios Paslakis, Valerie Glahn, Florian Lederbogen, Michael Deuschle |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1735645524 | ||
| 003 | DE-627 | ||
| 005 | 20240407193346.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201015s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/WNF.0b013e3181f0ec33 |2 doi | |
| 035 | |a (DE-627)1735645524 | ||
| 035 | |a (DE-599)KXP1735645524 | ||
| 035 | |a (OCoLC)1341371420 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Gilles, Maria |d 1972- |e VerfasserIn |0 (DE-588)137091877 |0 (DE-627)589925148 |0 (DE-576)302138528 |4 aut | |
| 245 | 1 | 0 | |a Visceral and subcutaneous fat in patients treated with olanzapine |b a case series |c Maria Gilles, Frank Hentschel, Georgios Paslakis, Valerie Glahn, Florian Lederbogen, Michael Deuschle |
| 264 | 1 | |c 2010 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.10.2020 | ||
| 520 | |a Objectives: - We hypothesized that olanzapine may contribute to visceral adiposity, a core symptom of metabolic syndrome. - Methods: - Using computed tomography, we examined the effect of olanzapine on visceral and subcutaneous fat distribution, body mass index, fasting glucose, and lipids in an unselected population of 14 schizophrenic patients. - Results: - We found a 6-week olanzapine treatment to be related to increased body mass index and proportion of total fat at the level of the fourth vertebral body. - Conclusions: - On the basis of these findings, we conclude that weight gain after a 6-week olanzapine treatment is partly attributable to increased visceral fat and may thus contribute to metabolic syndrome. | ||
| 700 | 1 | |a Hentschel, Frank |e VerfasserIn |0 (DE-588)1110919611 |0 (DE-627)865216525 |0 (DE-576)475836138 |4 aut | |
| 700 | 1 | |a Paslakis, Georgios |d 1978- |e VerfasserIn |0 (DE-588)134244591 |0 (DE-627)565613367 |0 (DE-576)300399472 |4 aut | |
| 700 | 1 | |a Glahn, Eva Valerie |d 1981- |e VerfasserIn |0 (DE-588)137451865 |0 (DE-627)695824392 |0 (DE-576)303155434 |4 aut | |
| 700 | 1 | |a Lederbogen, Florian |e VerfasserIn |0 (DE-588)1029138915 |0 (DE-627)732485444 |0 (DE-576)376591692 |4 aut | |
| 700 | 1 | |a Deuschle, Michael |d 1963- |e VerfasserIn |0 (DE-588)1029068801 |0 (DE-627)732393086 |0 (DE-576)376532408 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical neuropharmacology |d Philadelphia, Pa. : Lippincott Williams & Wilkins, 1976 |g 33(2010), 5, Seite 248-249 |h Online-Ressource |w (DE-627)330078143 |w (DE-600)2048796-4 |w (DE-576)09618888X |x 1537-162X |7 nnas |a Visceral and subcutaneous fat in patients treated with olanzapine a case series |
| 773 | 1 | 8 | |g volume:33 |g year:2010 |g number:5 |g pages:248-249 |g extent:2 |a Visceral and subcutaneous fat in patients treated with olanzapine a case series |
| 856 | 4 | 0 | |u https://doi.org/10.1097/WNF.0b013e3181f0ec33 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://journals.lww.com/clinicalneuropharm/Abstract/2010/09000/Visceral_and_Subcutaneous_Fat_in_Patients_Treated.7.aspx |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20201015 | ||
| 994 | |a 2010 | ||
| 998 | |g 1029068801 |a Deuschle, Michael |m 1029068801:Deuschle, Michael |d 60000 |e 60000PD1029068801 |k 0/60000/ |p 6 |y j | ||
| 998 | |g 1029138915 |a Lederbogen, Florian |m 1029138915:Lederbogen, Florian |d 60000 |e 60000PL1029138915 |k 0/60000/ |p 5 | ||
| 998 | |g 137451865 |a Glahn, Eva Valerie |m 137451865:Glahn, Eva Valerie |p 4 | ||
| 998 | |g 134244591 |a Paslakis, Georgios |m 134244591:Paslakis, Georgios |p 3 | ||
| 998 | |g 1110919611 |a Hentschel, Frank |m 1110919611:Hentschel, Frank |d 60000 |e 60000PH1110919611 |k 0/60000/ |p 2 | ||
| 998 | |g 137091877 |a Gilles, Maria |m 137091877:Gilles, Maria |d 60000 |e 60000PG137091877 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1735645524 |e 3780109174 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Gilles","given":"Maria","role":"aut","display":"Gilles, Maria"},{"role":"aut","given":"Frank","display":"Hentschel, Frank","family":"Hentschel"},{"given":"Georgios","role":"aut","display":"Paslakis, Georgios","family":"Paslakis"},{"given":"Eva Valerie","role":"aut","display":"Glahn, Eva Valerie","family":"Glahn"},{"family":"Lederbogen","role":"aut","given":"Florian","display":"Lederbogen, Florian"},{"display":"Deuschle, Michael","role":"aut","given":"Michael","family":"Deuschle"}],"name":{"displayForm":["Maria Gilles, Frank Hentschel, Georgios Paslakis, Valerie Glahn, Florian Lederbogen, Michael Deuschle"]},"physDesc":[{"extent":"2 S."}],"id":{"doi":["10.1097/WNF.0b013e3181f0ec33"],"eki":["1735645524"]},"note":["Gesehen am 15.10.2020"],"relHost":[{"recId":"330078143","origin":[{"publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1976","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedDisp":"1976-"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 11.02.03"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Visceral and subcutaneous fat in patients treated with olanzapine a case seriesClinical neuropharmacology","id":{"issn":["1537-162X"],"zdb":["2048796-4"],"eki":["330078143"]},"pubHistory":["1.1976 -"],"part":{"text":"33(2010), 5, Seite 248-249","year":"2010","volume":"33","issue":"5","extent":"2","pages":"248-249"},"language":["eng"],"title":[{"title_sort":"Clinical neuropharmacology","title":"Clinical neuropharmacology"}]}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1735645524","origin":[{"dateIssuedDisp":"2010","dateIssuedKey":"2010"}],"title":[{"title":"Visceral and subcutaneous fat in patients treated with olanzapine","subtitle":"a case series","title_sort":"Visceral and subcutaneous fat in patients treated with olanzapine"}],"language":["eng"]} | ||
| SRT | |a GILLESMARIVISCERALAN2010 | ||